论文信息 - No Clinical Impact of CYP3A5 Gene Polymorphisms on the Pharmacokinetics and/or Efficacy of Maraviroc in Healthy Volunteers and HIV‐1–Infected Subjects - 字舞流文

No Clinical Impact of CYP3A5 Gene Polymorphisms on the Pharmacokinetics and/or Efficacy of Maraviroc in Healthy Volunteers and HIV‐1–Infected Subjects

J. Marshall | P. Chan | S. Nepal | Kimberly Smith | L. Mcfadyen | M. Vourvahis | A. Nedderman | M. Savage | J. Heera | L. Wood | A. Fang | A. Clark | G. Fate | S. Valluri | Julian J Haynes